Tradestie Institutional Equity Comparison Engine

DMIIR vs DMAAR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DMAAR Overall Edge

DMAAR Captures Institutional Edge (1โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Drugs Made In America Acquisition Corp. Rights (DMAAR) driven by superior Momentum & Technical. Fundamentally, DMIIR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus DMAAR at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, DMIIR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DMAAR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
DMIIR N/M vs DMAAR N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner DMAAR
1Y -57.8% vs -40.5% ยท 52W Pos 15% vs 43%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DMIIR US Equity
DMIIR
Institutional Equity
$0.07
+7.31% 1D
Market Cap N/A
1M Return +12.69%
1Y Return -57.81%
Forward P/E N/M
Unified AI Score
33.1 / 100 SELL
Tech 30.0 Fund 42.0 Flow 50.0 Mom 50.0
DMAAR NASDAQ
Drugs Made In America Acquisition Corp. Rights
Blank Checks
$0.12
+0.0% 1D
Market Cap N/A
1M Return +0.0%
1Y Return -40.48%
Forward P/E N/M
Unified AI Score
43.5 / 100 HOLD
Tech 30.0 Fund 44.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DMIIR -57.81% DMAAR -40.48% Spread: +20.82 pp (DMAAR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DMIIR TTM Op. Margin: N/A DMAAR TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DMIIR vs DMAAR. Trailing 12-month operating profitability (DMIIR N/A vs DMAAR N/A) and valuation multiples (DMIIR N/M vs DMAAR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DMIIR (0) vs DMAAR (3)
Institutional Metric DMIIR DMAAR Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 15% ($0โ€“$0) 43% ($0โ€“$0) Stronger Trend DMAAR
Beta / 30D Volatility Risk Regime -0.53ฮฒ ยท 168% Vol 0.48ฮฒ ยท 147% Vol Lower Realized Risk DMAAR
Unified Institutional Score Composite Signal 33.1 / 100 (SELL) 43.5 / 100 (HOLD) Higher Composite DMAAR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DMIIR vs DMAAR Buy Guide
DMIIR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DMIIR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DMAAR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DMAAR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DMIIR nor DMAAR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.